CAS 120202-66-6
:Sulfato de hidrogênio de clopidogrel
Descrição:
Sulfato de hidrogênio de clopidogrel é um composto farmacêutico utilizado principalmente como agente antiplaquetário para prevenir coágulos sanguíneos em pacientes em risco de eventos cardiovasculares. É um pró-fármaco que requer ativação metabólica no fígado para exercer seus efeitos terapêuticos. A substância é caracterizada por sua capacidade de inibir irreversivelmente o receptor P2Y12 nas plaquetas, reduzindo assim a agregação plaquetária. Sulfato de hidrogênio de clopidogrel é tipicamente administrado por via oral e é conhecido por sua relativamente alta biodisponibilidade e longa meia-vida, permitindo uma dosagem uma vez ao dia. O composto é solúvel em água e apresenta estabilidade em condições normais de armazenamento, embora deva ser protegido da luz e da umidade. Os efeitos colaterais comuns podem incluir complicações hemorrágicas, distúrbios gastrointestinais e reações de hipersensibilidade. Devido ao seu mecanismo de ação, muitas vezes é prescrito em conjunto com outras terapias antiplaquetárias ou anticoagulantes, particularmente em pacientes com histórico de infarto do miocárdio ou acidente vascular cerebral. O monitoramento da eficácia e dos efeitos adversos é essencial durante o tratamento.
Fórmula:C15H16ClNO6S2
InChI:InChI=1/C15H14ClNO2S.H2O4S/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13;1-5(2,3)4/h1-4,6,8,14H,5,7,9H2,(H,18,19);(H2,1,2,3,4)/t14-;/m0./s1
Chave InChI:InChIKey=FDEODCTUSIWGLK-RSAXXLAASA-N
SMILES:[C@H](C(OC)=O)(N1CC2=C(CC1)SC=C2)C3=C(Cl)C=CC=C3.S(=O)(=O)(O)O
Sinónimos:- (+)-(S)-5-[(2-Chlorophenyl)(methoxycarbonyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]-pyridin-5-ium hydrogen sulfate]
- (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoic acid sulfate (1:1)
- (S)-(+)-Clopidogrel hydrogen sulfate
- (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate bisulfate
- (S)-(+)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate
- Areplex
- Clopidix
- Clopidogerl Bisulfate
- Clopidogrel Bisulfate
- Clopidogrel Bisulfate I
- Clopidogrel Bisulfate II
- Clopidogrel Bisulfate, FormI/FormII
- Clopidogrel Hydrogen Sulphate
- Clopidogrel Hydrogensulfate
- Clopidogrel Sulphate
- Clopidogrel bisulphate
- Clopidogrel bisulphate Ⅰ/Ⅱ
- Clopidogrel hemisulfate
- Clopidogrel sulfate
- Iscover
- Methyl (+)-(S)-A-(2-Chlorophenyl)-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)Acetate, Hydrogen Sulfate Salt
- Methyl (S)-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)(2-chlorophenyl)ethanoate hydrogen sulfate
- Myogrel
- Plavitor
- Plavix
- Sr 25990C
- Stroka
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-, sulfate (1:1)
- Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-, sulfate (1:1)
- Trombex
- Zyllt
- Clopidogrel hydrogen sulfate
- (S)-alpha-(2-Chlorophenyl)-6,7-dihydrothieno[3.2-c]pyridine-5(4H)-aceticacidmethylesterhydrogensulfate
- Clopidogrelhydrogenesulfate
- Clopidogrel (Hydrogen)
- (2-Chlorophenyl)-6,7–dihydrothieno[3,2-C]pyridine-5-(4H)-acetic acid methyl ester sulfate
- d-Clopidogrel
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 20 produtos.
CLOPIDOGREL HYDROGEN SULFATE CRS
CAS:CLOPIDOGREL HYDROGEN SULFATE CRSFórmula:C16H18ClNO6S2Cor e Forma:White. Whitish. Powder.Peso molecular:419.9002Clopidogrel hydrogen sulfate
CAS:Clopidogrel hydrogen sulfateFórmula:C16H18ClNO6S2Pureza:99.4%Cor e Forma:Off-WhitePeso molecular:419.02641Clopidogrel Bisulfate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H16ClNO2S·H2SO4Cor e Forma:White Off-White PowderPeso molecular:321.05903Clopidogrel hydrogen sulfate
CAS:Clopidogrel hydrogen sulfate is a selective P2Y12 receptor blocker that inhibits platelet adhesion and aggregation.Fórmula:C16H16ClNO2S·H2SO4Pureza:99.57% - 99.79%Cor e Forma:SolidPeso molecular:419.9Clopidogrel hydrogen sulfate
CAS:Clopidogrel hydrogen sulfateFórmula:C16H16ClNO2S·H2SO4Pureza:≥98%Peso molecular:419.9Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulfate (1:1)
CAS:Fórmula:C16H18ClNO6S2Pureza:99%Cor e Forma:SolidPeso molecular:419.9002Clopidogrel Sulfate
CAS:Fórmula:C16H16ClNO2S·H2SO4Cor e Forma:White To Off-White SolidPeso molecular:321.82 98.07(S)-(+)-Clopidogrel Sulfate
CAS:Fórmula:C16H16ClNO2S·H2SO4Pureza:>98.0%(HPLC)(N)Cor e Forma:White to Almost white powder to crystalPeso molecular:419.89(S)-(+)-Clopidogrel hydrogen sulfate
CAS:Fórmula:C16H16ClNO2S·H2SO4Pureza:≥ 98.0%Cor e Forma:White to off-white powderPeso molecular:419.90Clopidogrel hydrogen sulfate
CAS:Methyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfateFórmula:C16H18ClNO6S2Pureza:98%Peso molecular:419.9S-(+)-Clopidogrel Hydrogen Sulfate
CAS:Applications Used as an antithrombotic.
References Mills, D.C.B., et al.: Arterioscler. Thromb., 12, 430 (1992), Feuerstein, G., et al.: Exp. Opin. Invest. Drugs, 4, 425 (1995)Fórmula:C16H16ClNO2S·H2O4SCor e Forma:NeatPeso molecular:419.9S-(+)-Clopidogrel hydrogen sulfate - Bio-X ™
CAS:Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.Fórmula:C16H16ClNO2S•H2SO4Pureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:419.9 g/molS-(+)-Clopidogrel hydrogen sulfate
CAS:Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.
Fórmula:C16H18ClNO6S2Pureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:419.9 g/mol(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate
CAS:Fórmula:C16H18ClNO6S2Pureza:99%Cor e Forma:LiquidPeso molecular:419.89
![Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulf…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00ILNY.jpg&w=3840&q=75)
![(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb%2FF092016.jpg&w=3840&q=75)
